In this prospective cohort trial, teens with significant ADHD symptoms were slightly more likely to be associated with a higher frequency of digital media use.
The 7 treatments included in the study were amphetamines (including lisdexamfetamine), atomoxetine, bupropion, clonidine, guanfacine, methylphenidate, and modafinil.
Jornay PM utilizes the proprietary Delexis drug delivery platform which consists of 2 functional film coatings: the first layer delays the initial drug release for up to 10 hours and the second layer helps control the release rate of the active ingredient throughout the day.
These results indicate an association between adolescent engagement in digital media activities and subsequent ADHD symptoms.
There is a modest, but statistically significant, association between higher frequency of digital media use and subsequent symptoms of ADHD among adolescents.
These findings illustrate potential gains of reducing the number of preterm births and the importance of providing custom support to children born preterm to prevent neurodevelopmental problems.
Nonstimulants may be an appropriate alternative in cases in which co-occurring conditions might prevent the administration of stimulants.
Food insecurity may be linked to behavioral problems and poorer cognitive performance in children.
The high risk for several neuropsychiatric and developmental disorders supports more extended use of genetic testing in child and adolescent psychiatry.
Early preterm birth is associated with a higher level of ADHD symptoms in preschool children.
Investigators conducted a retrospective observational study to assess the impact of psychostimulant medication on BMI and height in a group of children and adolescents with ADHD.
Medication continuity in youth with ADHD is affected by several potentially modifiable factors that could be productive targets of intervention for pediatricians.
Exposure to hypertensive disorders of pregnancy may be associated with an increase in the risk for ASD and ADHD in offspring.
These findings offer preliminary evidence of the validity of the short UPPS-P-C to screen for impulsivity traits in both typically developing children and in those with ADHD.
While the authors discovered no "sensitive period," the number of stressful events was moderately associated with the severity of attention-deficit/hyperactivity disorder symptoms.
There are considerable gaps in knowledge relating to the effectiveness of nonpharmacologic treatments for ADHD in pediatric patients.
The results of the study point to effective alternatives to psychopharmacologic treatments with methylphenidate for patients who experience nonresponse, contraindications, or adverse events, or for patients who prefer nonpsychopharmacologic treatments.
Just as we need to be able to identify who is likely to benefit from treatment, we also need to be able to identify those who are most at risk of experiencing adverse events.
Antipsychotics have been shown to reduce tic severity, as has behavior therapy. However, the mechanisms behind the efficacy of behavior therapy have yet to be clarified by research.
These findings may raise new hypotheses for understanding the origins of ADHD, gender differences, and future targets in the prevention of ADHD.
There is a link between language delays in girls, and acetaminophen use in pregnancy.
The study's lead investigator said prior research shows a high prevalence of obstructive sleep apnea in school-age children with juvenile idiopathic arthritis.
Infants with postnatal etiology showed worse developmental deficits across all domains.
Study results suggest continued study of arbaclofen for autism spectrum disorder.
Autism is a heritable neurodevelopmental disorder that is approximately 4 times more prevalent in males than females.
Investigators examined functional connectivity between the amygdala and the mPFC, bilateral temporal lobe, striatum, thalamus, cingulate cortex, and cerebellum in children diagnosed with autism and age-matched control participants.
Maternal tobacco smoking during pregnancy has previously been linked with numerous long-term neurodevelopmental abnormalities and child behavioral problems.
While past studies have shown that younger siblings with an affected older sibling are at higher risk of autism, these findings have not been evaluated in a large, racially and ethnically diverse population.
The longer autism spectrum disorder insurance mandates remained in place, the more that mandate-associated treated prevalence increased.
In vitro assays hold promise as diagnostic tools in complex neurodevelopmental disorders such as autism.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Age of Onset of Bipolar Disorder Linked With Substance Use Disorders
- Rapid Cycling in Bipolar Disorder: Overview and Expert Perspectives
- Low Testosterone Linked With Social Anxiety in Boys With Klinefelter Syndrome
- Posttraumatic Stress Disorder Associated With Reduced Brain Volume
- First-Episode Drug-Naive Patients With Schizophrenia More Likely to Attempt Suicide
- The Psychology of Hoarding Disorder: Approaches for Treatment
- Mind-Body Therapy and Psychiatry: Ancient Tools for Modern Practice
- Smartphone Applications for Depression and Anxiety: Are They Ready for Widespread Use?
- The Many Misconceptions of Catatonia: Treatment Is Often Successful With the Right Knowledge
- Marijuana Use Associated With Poorer Depression Outcomes, Increased Suicidal Ideation
- Healthcare Community Should Favor More Restrictive Alcohol Policies
- How to Respond to a Patient's Request for Prayer: A Clinician's Dilemma
- Major Barriers to Useful Risk Prediction Must Be Overcome to Reach the Full Potential of Big Data
- ACA Coverage Gains Include Workers Without Insurance
- Steps Provided for Discharging Patients From Practice